- 专利标题： PHARMACEUTICAL COMPOSITION COMPRISING COMPOUND CAPABLE OF PENETRATING BLOOD-BRAIN BARRIER AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING BRAIN CANCER
-
申请号： EP18758340.6申请日： 2018-02-23
-
公开(公告)号： EP3586848A1公开(公告)日： 2020-01-01
- 发明人: CHOI, Hwan Geun , PARK, Jong Bae , KO, Eunhwa , SON, Jung Beom , KIM, Nam Doo , LEE, Seung Hoon , NAM, Do-Hyun
- 申请人： Daegu-Gyeongbuk Medical Innovation Foundation , National Cancer Center , Samsung Life Public Welfare Foundation
- 申请人地址： 88 Dongnae-ro Dong-gu Daegu 41061 KR
- 专利权人： Daegu-Gyeongbuk Medical Innovation Foundation,National Cancer Center,Samsung Life Public Welfare Foundation
- 当前专利权人： Daegu-Gyeongbuk Medical Innovation Foundation,National Cancer Center,Samsung Life Public Welfare Foundation
- 当前专利权人地址： 88 Dongnae-ro Dong-gu Daegu 41061 KR
- 代理机构： Office Freylinger
- 优先权： KR20170024812 20170224
- 国际公布： WO2018155947 20180830
- 主分类号： A61K31/505
- IPC分类号： A61K31/505 ; A61K31/506 ; A61K31/437 ; A61K31/415 ; A61K31/519 ; A61K31/5377 ; A23L33/10
摘要：
Disclosed is a pharmaceutical composition for the prevention or treatment of brain cancer, containing a compound capable of penetrating the blood-brain barrier as an active ingredient, the pharmaceutical composition for the prevention or treatment of brain cancer is capable of efficiently penetrating the blood-brain barrier of the brain to thereby effectively inhibit LRRK2 protein expression, and is thus useful in the prevention or treatment of brain cancer.
公开/授权文献
信息查询
